Partnering on vaccines to protect humans against emerging and re-emerging diseases is old hat for GlaxoSmithKline PLC and the National Institutes of Health (NIH), which have long-been collaborators on several products, including an investigational Ebola vaccine.
But the path the two parties are now undertaking in their pursuit of a Zika virus vaccine is expected to...







![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)